7-20784862-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_182700.6(SP8):c.955G>A(p.Gly319Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,525,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_182700.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000856 AC: 13AN: 151942Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000834 AC: 1AN: 119882Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66322
GnomAD4 exome AF: 0.00000801 AC: 11AN: 1372956Hom.: 0 Cov.: 38 AF XY: 0.00000443 AC XY: 3AN XY: 677336
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152054Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.955G>A (p.G319S) alteration is located in exon 2 (coding exon 2) of the SP8 gene. This alteration results from a G to A substitution at nucleotide position 955, causing the glycine (G) at amino acid position 319 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at